Invivo Therapeutics Holdings Corp.
NVIVDelisted Mar 21, 2024- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001292519
Invivo Therapeutics Holdings Corp. was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Feb 7, 2024; 14 institutions reported holding it in 13F filings for Q4 2023, worth $68.1K in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in Invivo Therapeutics Holdings Corp. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- −5 vs. Q1 2023
- Shares held
- 97.2K
- −19.3K (−16.5%) vs. Q1 2023
- Total value
- $131.0K
- +$7.30K (+5.9%) vs. Q1 2023
- New holders
- 1
- 3 more added
- Sold out
- 6
- 2 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NVIV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 4 | $5.22K |
| Q4 2023 | 14 | $68.1K |
| Q3 2023 | 15 | $118.5K |
| Q2 2023 | 15 | $131.0K |
| Q1 2023 | 20 | $123.7K |
| Q4 2022 | 17 | $718.7K |
| Q3 2022 | 16 | $703.0K |
| Q2 2022 | 13 | $257.0K |
| Q1 2022 | 1 | $1.00K |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Invivo Therapeutics Holdings Corp.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 34,714 | $46.9K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 26,246 | $35.4K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 17,266 | $23.0K | 0.00% | +6,241+56.6% | Added |
| Geode Capital Management, LLC | 11,169 | $15.2K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 7,391 | $9.98K | 0.00% | +5,607+314.3% | Added |
| Morgan Stanley | 270 | $364 | 0.00% | −1,199−81.6% | Reduced |
| FMR LLC | 73 | $99 | 0.00% | +73 | New |
| Wells Fargo & Company | 22 | $30 | 0.00% | +9+69.2% | Added |
| TD Waterhouse Canada Inc. | 6 | $11 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 7 | $8 | 0.00% | 00.0% | Unchanged |
| Colonial Trust Advisors | 2 | $3 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 1 | $2 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1 | $1 | 0.00% | −3,739−100.0% | Reduced |
| WealthPLAN Partners, LLC | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Sugarloaf Wealth Management, LLC | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 0 | $0 | 0.00% | −13,280−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −12,870−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Milestone Investment Advisors LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −69−100.0% | Sold out |